Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 286

Similar articles for PubMed (Select 23107591)

1.

Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.

Couch RB, Atmar RL, Keitel WA, Quarles JM, Wells J, Arden N, Niño D.

Vaccine. 2012 Dec 17;31(1):190-5. doi: 10.1016/j.vaccine.2012.10.065. Epub 2012 Oct 26.

2.

Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season.

Chambers BS, Parkhouse K, Ross TM, Alby K, Hensley SE.

Cell Rep. 2015 Jun 24. pii: S2211-1247(15)00588-4. doi: 10.1016/j.celrep.2015.06.005. [Epub ahead of print]

3.

Self-administration of intranasal influenza vaccine: Immunogenicity and volunteer acceptance.

Burgess TH, Murray CK, Bavaro MF, Landrum ML, O'Bryan TA, Rosas JG, Cammarata SM, Martin NJ, Ewing D, Raviprakash K, Mor D, Zell ER, Wilkins KJ, Millar EV.

Vaccine. 2015 Jun 25. pii: S0264-410X(15)00862-2. doi: 10.1016/j.vaccine.2015.06.061. [Epub ahead of print]

PMID:
26117150
4.

A 2013/2014 Northern Hemisphere Season Surface Antigen Inactivated Trivalent Influenza Vaccine - Assessing the Immunogenicity and Safety in an Open Label, Uncontrolled Study.

Roggelin L, Vinnemeier CD, Meyer S, Witte K, Marx L, Theeß W, Burchard GD, Rolling T, Cramer JP.

Hum Vaccin Immunother. 2015 Jun 26:0. [Epub ahead of print]

PMID:
26114800
5.

Systematic review of fever, febrile convulsions and serious adverse events following administration of inactivated trivalent influenza vaccines in children.

Li-Kim-Moy J, Yin JK, Rashid H, Khandaker G, King C, Wood N, Macartney KK, Jones C, Booy R.

Euro Surveill. 2015 Jun 18;20(24). pii: 21159. No abstract available.

6.

Microneutralization Assay Titres Correlate with Protection against Seasonal Influenza H1N1 and H3N2 in Children.

Verschoor CP, Singh P, Russell ML, Bowdish DM, Brewer A, Cyr L, Ward BJ, Loeb M.

PLoS One. 2015 Jun 24;10(6):e0131531. doi: 10.1371/journal.pone.0131531. eCollection 2015.

7.

Multi-Dimensional Measurement of Antibody-Mediated Heterosubtypic Immunity to Influenza.

Wang J, Hilchey SP, Hyrien O, Huertas N, Perry S, Ramanunninair M, Bucher D, Zand MS.

PLoS One. 2015 Jun 23;10(6):e0129858. doi: 10.1371/journal.pone.0129858. eCollection 2015.

8.

Influenza bivalent vaccine comprising recombinant H3 hemagglutinin (HA) and H1 HA containing replaced H3 hemagglutinin transmembrane domain exhibited improved heterosubtypic protection immunity in mice.

Liu Q, Xue C, Zheng J, Liu K, Wang Y, Wei Y, Liu GD, Cao Y.

Vaccine. 2015 Jun 19. pii: S0264-410X(15)00696-9. doi: 10.1016/j.vaccine.2015.05.044. [Epub ahead of print]

PMID:
26100927
9.

Fluarix quadrivalent vaccine for influenza.

Graaf H, Faust SN.

Expert Rev Vaccines. 2015 Jun 22:1-9. [Epub ahead of print]

PMID:
26098443
10.

Investigation into alternative testing methodologies for characterization of influenza virus vaccine.

Tay T, Agius C, Hamilton R, Bodle J, Rockman S.

Hum Vaccin Immunother. 2015 Jun 19:0. [Epub ahead of print]

PMID:
26090618
11.

H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance.

Liu R, Moise L, Tassone R, Gutierrez AH, Terry FE, Sangare K, Ardito MT, Martin WD, De Groot AS.

Hum Vaccin Immunother. 2015 Jun 19:0. [Epub ahead of print]

PMID:
26090577
12.

Statistical modeling using early markers of innate immunity to explain variation in humoral responses to influenza vaccine in older adults.

Kennedy RB, Tosh PK, Goergen KM, Grill DE, Oberg AL, Poland GA.

Vaccine. 2015 Jul 17;33(31):3682-8. doi: 10.1016/j.vaccine.2015.06.031. Epub 2015 Jun 16.

PMID:
26087295
13.

Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice.

Shin JH, Park JK, Lee DH, Quan FS, Song CS, Kim YC.

PLoS One. 2015 Jun 18;10(6):e0130684. doi: 10.1371/journal.pone.0130684. eCollection 2015.

14.

Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.

Bai Y, Shi N, Lu Q, Yang L, Wang Z, Li L, Han H, Zheng D, Luo F, Zhang Z, Ai X.

Hum Vaccin Immunother. 2015 Jun 17:0. [Epub ahead of print]

PMID:
26083828
15.

BCG-vaccination enhances immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized placebo-controlled pilot study.

Leentjens J, Kox M, Stokman R, Gerretsen J, Diavatopoulos DA, van Crevel R, Rimmelzwaan GF, Pickkers P, Netea MG.

J Infect Dis. 2015 Jun 12. pii: jiv332. [Epub ahead of print]

PMID:
26071565
16.

Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs.

Johnson A, Chen LM, Winne E, Santana W, Metcalfe MG, Mateu-Petit G, Ridenour C, Hossain MJ, Villanueva J, Zaki SR, Williams TL, Cox NJ, Barr JR, Donis RO.

PLoS One. 2015 Jun 11;10(6):e0128982. doi: 10.1371/journal.pone.0128982. eCollection 2015.

17.

Antibody responses after vaccination against equine influenza in the Republic of Korea in 2013.

Kim EJ, Kim BH, Yang SJ, Choi EJ, Shin YJ, Song JY, Shin YK.

J Vet Med Sci. 2015 Jun 9. [Epub ahead of print]

18.

Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice.

Barroso SP, Nico D, Nascimento D, Santos AC, Couceiro JN, Bozza FA, Ferreira AM, Ferreira DF, Palatnik-de-Sousa CB, Souza TM, Gomes AM, Silva JL, Oliveira AC.

PLoS One. 2015 Jun 9;10(6):e0128785. doi: 10.1371/journal.pone.0128785. eCollection 2015.

19.

Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.

Itoh Y, Shichinohe S, Nakayama M, Igarashi M, Ishii A, Ishigaki H, Ishida H, Kitagawa N, Sasamura T, Shiohara M, Doi M, Tsuchiya H, Nakamura S, Okamatsu M, Sakoda Y, Kida H, Ogasawara K.

Antimicrob Agents Chemother. 2015 Jun 8. pii: AAC.00793-15. [Epub ahead of print]

PMID:
26055368
20.

Reactogenicity of trivalent inactivated influenza vaccine in young children: Pronounced reactions by previous successive vaccinations.

Okada C, Fujieda M, Fukushima W, Ohfuji S, Kondo K, Maeda A, Nakano T, Kaji M, Hirota Y; Influenza Vaccine Epidemiology Study Group.

Vaccine. 2015 Jul 9;33(30):3586-91. doi: 10.1016/j.vaccine.2015.05.040. Epub 2015 Jun 1.

PMID:
26044492
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk